✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Brawn Biotech Ltd.

BRAWN

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹6 Cr.
P/E
0.00

Brawn Biotech Ltd.

  • Brawn Biotech
  • Fraser and Co
  • Ramasigns Industries

FAQs on Brawn Biotech Ltd. Shareprice

Brawn Biotech has given lower returns compared to its competitors.
Brawn Biotech has grown at ~-12.9% over the last 8yrs while peers have grown at a median rate of 5.09%

Brawn Biotech is not expensive.
Latest PE of Brawn Biotech is 0.0, while 3 year average PE is 0.9.
Also latest EV/EBITDA of Brawn Biotech is 0.0 while 3yr average is 4.92.

View FAQ's On Business

Growth Table

  • Brawn Biotech Ltd.
  • Fraser and Co
  • Ramasigns Industries

Balance Sheet

  • Brawn Biotech Ltd.
  • Fraser and Co
  • Ramasigns Industries

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Brawn Biotech Ltd.
  • Fraser and Co
  • Ramasigns Industries

Cash Flow

  • Brawn Biotech Ltd.
  • Fraser and Co
  • Ramasigns Industries

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Brawn Biotech Ltd.
  • Fraser and Co
  • Ramasigns Industries

Quarterly Results

  • Brawn Biotech Ltd.
  • Fraser and Co
  • Ramasigns Industries

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Brawn Biotech Ltd. Financials

Balance sheet of Brawn Biotech is moderately strong.

Yes, The net debt of Brawn Biotech is increasing.
Latest net debt of Brawn Biotech is -₹0.2 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹0.79 Crs.

The profit is oscillating.
The profit of Brawn Biotech is -₹1.04 Crs for TTM, -₹1.24 Crs for Mar 2024 and -₹0.91 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Brawn Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech